Hologic, Inc. (HOLX) Monthly Stock Report
Publication Date: September 22, 2024
Company Overview
Hologic, Inc. (HOLX), headquartered in Marlborough, Massachusetts, is a leader in providing innovative diagnostic products, medical imaging systems, and surgical solutions tailored for women’s health. Established in 1985, the company operates within the healthcare sector, specifically in the medical instruments and supplies industry. Hologic is organized into four primary segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The organization specializes in molecular diagnostic assays and advanced surgical systems aimed at enhancing patient outcomes and elevating the quality of care in women’s health.
With a robust operational performance, Hologic reported total revenues of approximately $3.99 billion, showcasing its solid market presence and financial health. The medical instruments industry is currently poised for significant growth, and Hologic’s market strategies position it well to capitalize on emerging trends in healthcare technology and patient care.
Financial Highlights and Investment Outlook
Hologic’s current stock price is $81.39, slightly below its fifty-day moving average of $80.75. Analysts project a target high price of $96.00, indicating considerable upside potential for investors in the coming months. The mean target price is estimated at $88.36, forming a positive consensus among market analysts. With a recommendation key indicating a “buy” status, supported by a favorable mean recommendation score of 2.2 derived from 14 analyst opinions, investor sentiment remains distinctly optimistic regarding Hologic’s performance.
The current market dynamics also reveal that Hologic has 232,272,000 shares outstanding, with only 5,610,963 shares held short—approximately 0.0363% of the total float—suggesting a strong level of confidence among investors. This optimistic outlook is further supported by the stock’s price performance over the past year, where it reached a fifty-two-week high of $84.67 and a low of $64.02. Collectively, these factors point toward a healthy growth trajectory for Hologic, making it an attractive investment opportunity within the evolving landscape of healthcare.
| Metric | Value |
|---|---|
| Market Cap | $18.9b |
| Total Debt | $2.6b |
| Total Cash | $2.4b |
| Shares Outstanding | 232.3m |
| Float Shares | 229.1m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.